Page 1813 - Hematology_ Basic Principles and Practice ( PDFDrive )

Chapter 105 Unrelated Donor Hematopoietic Cell Transplantation 1616.e1

REFERENCES 21. Erlich HA: HLA typing using next generation sequencing: an overview.
Hum Immunol 2015. [Epub ahead of print].
1. Foeken LM, Green A, Hurley CK, et al: Monitoring the international 22. Wittig M, Anmarkrud JA, Kässens JC, et al: Development of a high-
use of unrelated donors for transplantation: the WMDA annual reports. resolution NGS-based HLA-typing and analysis pipeline. Nucleic Acids
Bone Marrow Transplant 45:811–818, 2010. Res 2015. [Epub ahead of print].
2. Gragert L, Eapen M, Williams E, et al: HLA match likelihoods for hema- 23. Ehrenberg PK, Geretz A, Baldwin KM, et al: High-throughput multi-
topoietic stem-cell grafts in the U.S. registry. N Engl J Med 371:339–348, plex HLA genotyping by next-generation sequencing using multi-locus
2014. individual tagging. BMC Genomics 15:864, 2014.
3. Pidala J, Kim J, Schell M, et al: Race/ethnicity affects the probability 24. Zhou M, Gao D, Chai X, et al: Application of high-throughput, high-
of finding an HLA-A, -B, -C and -DRB1 allele-matched unrelated resolution and cost-effective next generation sequencing-based large-scale
donor and likelihood of subsequent transplant utilization. Bone Marrow HLA typing in donor registry. Tissue Antigens 85:20–28, 2015.
Transplant 48:346–350, 2013. 25. Anasetti C, Hansen JA: Effect of HLA incompatibility in marrow
4. Lee SJ, Klein J, Haagenson M, et al: High-resolution donor-recipient transplantation from unrelated and HLA-mismatched related donors.
HLA matching contributes to the success of unrelated donor marrow Transfus Sci 15:221–230, 1994.
transplantation. Blood 110:4576–4583, 2007. 26. Hurley CK, Woolfrey A, Wang T, et al: The impact of HLA unidirec-
5. Anasetti C, Amos D, Beatty PG, et al: Effect of HLA compatibility on tional mismatches on the outcome of myeloablative hematopoietic stem
engraftment of bone marrow transplants in patients with leukemia or cell transplantation with unrelated donors. Blood 121:4800–4806, 2013.
lymphoma. N Engl J Med 320:197–204, 1989. 27. Anasetti C, Amos D, Beatty PG, et al: Effect of HLA compatibility on
6. Ciurea SO, Thall PF, Wang X, et al: Donor-specific anti-HLA Abs engraftment of bone marrow transplants in patients with leukemia or
and graft failure in matched unrelated donor hematopoietic stem cell lymphoma. N Engl J Med 320:197–204, 1989.
transplantation. Blood 118:5957–5964, 2011. 28. Anasetti C, Hansen JA: Effect of HLA incompatibility in marrow
7. Takanashi M, Atsuta Y, Fujiwara K, et al: The impact of anti-HLA anti- transplantation from unrelated and HLA-mismatched related donors.
bodies on unrelated cord blood transplantations. Blood 116:2839–2846, Transfus Sci 15:221–230, 1994.
2010. 29. Lee SJ, Klein J, Haagenson M, et al: High-resolution donor-recipient
8. Cutler C, Kim HT, Sun L, et al: Donor-specific anti-HLA antibodies HLA matching contributes to the success of unrelated donor marrow
predict outcome in double umbilical cord blood transplantation. Blood transplantation. Blood 110:4576–4583, 2007.
118:6691–6697, 2011. 30. Hurley CK, Woolfrey A, Wang T, et al: The impact of HLA unidirec-
9. Brunstein CG, Noreen H, Defor TE, et al: Anti-HLA antibodies in tional mismatches on the outcome of myeloablative hematopoietic stem
double umbilical cord blood transplantation. Biol Blood Marrow Trans- cell transplantation with unrelated donors. Blood 121:4800–4806, 2013.
plant 17:1704–1708, 2011. 31. Morishima Y, Kashiwase K, Matsuo K, et al: Biological significance of
10. Ruggeri A, Rocha V, Masson E, et al: Impact of donor-specific anti- HLA locus matching in unrelated donor bone marrow transplantation.
HLA antibodies on graft failure and survival after reduced intensity Blood 125:1189–1197, 2015.
conditioning-unrelated cord blood transplantation: a Eurocord, Societe 32. Petersdorf EW, Hansen JA, Martin PJ, et al: Major-histocompatibility-
Francophone d’Histocompatibilite et d’Immunogenetique (SFHI) and complex class I alleles and antigens in hematopoietic-cell transplantation.
Societe Francaise de Greffe de Moelle et de Therapie Cellulaire (SFGM- N Engl J Med 345:1794–1800, 2001.
TC) analysis. Haematologica 98:1154–1160, 2013. 33. Woolfrey A, Klein JP, Haagenson M, et al: HLA-C antigen mismatch is
11. Yamamoto H, Uchida N, Matsuno N, et al: Anti-HLA antibodies associated with worse outcome in unrelated donor peripheral blood stem
other than against HLA-A, -B, -DRB1 adversely affect engraftment and cell transplantation. Biol Blood Marrow Transplant 17:885–892, 2011.
nonrelapse mortality in HLA-mismatched single cord blood transplanta- 34. Petersdorf EW, Gooley TA, Malkki M, et al: HLA-C expression levels
tion: possible implications of unrecognized donor-specific antibodies. define permissible mismatches in hematopoietic cell transplantation.
Biol Blood Marrow Transplant 20:1634–1640, 2014. Blood 124:3996–4003, 2014.
12. Yoshihara S, Taniguchi K, Ogawa H, et al: The role of HLA antibodies 35. Fernandez-Vina MA, Klein JP, Haagenson M, et al: Multiple mismatches
in allogeneic SCT: is the ‘type-and-screen’ strategy necessary not only at the low expression HLA loci DP, DQ, and DRB3/4/5 associate with
for blood type but also for HLA? (Review). Bone Marrow Transplant adverse outcomes in hematopoietic stem cell transplantation. Blood
47:1499–1506, 2012. 121:4603–4610, 2013.
13. Shaw BE, Ball L, Beksac M, et al: Donor safety: the role of the WMDA 36. Fleischhauer K, Shaw BE, Gooley T, et al: Effect of T-cell-epitope match-
in ensuring the safety of volunteer unrelated donors: clinical and ethical ing at HLA-DPB1 in recipients of unrelated-donor haemopoietic-cell
considerations. Bone Marrow Transplant 45:832–838, 2010. transplantation: a retrospective study.[Erratum appears in Lancet Oncol.
14. Navarro WH, Switzer GE, Pulsipher M: National marrow donor 2012 Apr;13(4):e134-5]. Lancet Oncol 13:366–374, 2012.
program session: donor issues (Review). Biol Blood Marrow Transplant 37. Zino E, Frumento G, Marktel S, et al: A T-cell epitope encoded by a
19:S15–S19, 2013. subset of HLA-DPB1 alleles determines nonpermissive mismatches for
15. Anasetti C, Logan BR, Lee SJ, et al: Peripheral-blood stem cells versus hematologic stem cell transplantation. Blood 103:1417–1424, 2004.
bone marrow from unrelated donors. N Engl J Med 367:1487–1496, 38. Pidala J, Lee SJ, Ahn KW, et al: Nonpermissive HLA-DPB1 mismatch
2012. increases mortality after myeloablative unrelated allogeneic hematopoi-
16. Shaw BE, Confer DL, Hwang W, et al: A review of the genetic and etic cell transplantation. Blood 124:2596–2606, 2014.
long-term effects of G-CSF injections in healthy donors: a reassuring 39. Woolfrey A, Klein JP, Haagenson M, et al: HLA-C antigen mismatch is
lack of evidence for the development of haematological malignancies. associated with worse outcome in unrelated donor peripheral blood stem
Bone Marrow Transplant 50:334–340, 2015. cell transplantation. Biol Blood Marrow Transplant 17:885–892, 2011.
17. Loacker K, Hortnagl P, Grabmer C, et al: A novel HLA-A allele detected 40. Verneris MR, Lee SJ, Ahn KW, et al: HLA mismatch is associated with
by sequence-based typing: a*68:66. Tissue Antigens 78:397, 2011. worse outcomes after unrelated donor reduced-intensity conditioning
18. Testi M, Troiano M, Di LA, et al: The novel HLA-C*06:58 allele, hematopoietic cell transplantation: an analysis from the Center for
identified by sequence-based typing in an Italian family. Tissue Antigens International Blood and Marrow Transplant Research. Biol Blood Marrow
79:80–81, 2012. Transplant 21:1783–1789, 2015.
19. Voorter CE, Palusci F, Tilanus MG: Sequence-based typing of HLA: an 41. Fleischhauer K, Locatelli F, Zecca M, et al: Graft rejection after unre-
improved group-specific full-length gene sequencing approach. Methods lated donor hematopoietic stem cell transplantation for thalassemia is
Mol Biol 1109:101–114, 2014. associated with nonpermissive HLA-DPB1 disparity in host-versus-graft
20. Smith AG, Pyo CW, Nelson W, et al: Next generation sequencing direction. Blood 107:2984–2992, 2006.
to determine HLA class II genotypes in a cohort of hematopoietic 42. Morishima Y, Kashiwase K, Matsuo K, et al: Biological significance of
cell transplant patients and donors. Hum Immunol 75:1040–1046, HLA locus matching in unrelated donor bone marrow transplantation.
2014. Blood 125:1189–1197, 2015.